Michael Schrader
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Schrader has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
Markus Islinger
Institute of Neuroanatomy, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, University of Heidelberg, 68167, Mannheim, Germany
19 shared publications- Joseph L. Costello
University of Exeter 1 Biosciences Exeter EX4 4QD
14 shared publications Tina A. Schrader
Biosciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK
14 shared publications- Ruth Ellen Carmichael
University of Exeter
10 shared publications - Markus Islinger
Institute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany
9 shared publications Christian Hacker
University of Exeter 1 College of Life and Environmental Sciences, Biosciences , Exeter EX4 4QD , UK
8 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 9
ACBD5 as a Master Tether of Peroxisomes: Integrating Organelle Contact Sites, Lipid Sensing, and Cellular Homeostasis
Acyl-CoA-binding domain-containing proteins (ACBDs) constitute a large and diverse multigene family involved in cellular lipid metabolism. Among them, the tail-anchored peroxisomal membrane protein ACBD5 has emerged as a key component of peroxisome–endoplasmic reticulum (ER) contact sites through its interaction with VAMP-associated proteins (VAPs). More recently, ACBD5 has also been implicated in peroxisome–mitochondria tethering under conditions of oxidative stress. Although initially characterized as a lipid-binding peroxisomal membrane protein, ACBD5 is increasingly recognized as a central mediator of inter-organelle cooperation. Here, we propose an expanded view of ACBD5 function, suggesting that it acts as a peroxisomal “master tether” that integrates intracellular organisation with metabolic and homeostatic regulation. By linking lipid sensing and metabolism to the formation and regulation of membrane contact sites, ACBD5 may serve as a key organizer of peroxisomal interactions within the cellular organelle network. We discuss the role of peroxisomes as interconnected hubs of cellular cooperation, examine the functions of ACBD5 at peroxisome–ER contact sites and beyond, highlight its relevance to human disease, and present a conceptual framework for understanding ACBD5 as a peroxisomal master tether.
- 5 August 2026
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 9
Open AccessACBD5 as a Master Tether of Peroxisomes: Integrating Organelle Contact Sites, Lipid Sensing, and Cellular Homeostasis
Acyl-CoA-binding domain-containing proteins (ACBDs) constitute a large and diverse multigene family involved in cellular lipid metabolism. Among them, the tail-anchored peroxisomal membrane protein ACBD5 has emerged as a key component of peroxisome–endoplasmic reticulum (ER) contact sites through its interaction with VAMP-associated proteins (VAPs). More recently, ACBD5 has also been implicated in peroxisome–mitochondria tethering under conditions of oxidative stress. Although initially characterized as a lipid-binding peroxisomal membrane protein, ACBD5 is increasingly recognized as a central mediator of inter-organelle cooperation. Here, we propose an expanded view of ACBD5 function, suggesting that it acts as a peroxisomal “master tether” that integrates intracellular organisation with metabolic and homeostatic regulation. By linking lipid sensing and metabolism to the formation and regulation of membrane contact sites, ACBD5 may serve as a key organizer of peroxisomal interactions within the cellular organelle network. We discuss the role of peroxisomes as interconnected hubs of cellular cooperation, examine the functions of ACBD5 at peroxisome–ER contact sites and beyond, highlight its relevance to human disease, and present a conceptual framework for understanding ACBD5 as a peroxisomal master tether.
- Open Access
- 20 May 2026
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 164 (1)
Visualisation of peroxisomes: a journey through seven decades
Peroxisomes are ubiquitous, oxidative organelles in eukaryotes with conserved functions in cellular lipid metabolism and redox balance. They are now recognised as key metabolic organelles of medical importance, with contributions to antiviral signalling, pathogen defence, innate immunity, cancer and neurodegeneration. Our current knowledge of peroxisomes and the molecular understanding of their diverse functions and roles in disease have been achieved through a combination of biochemical and morphological studies. This review provides a comprehensive overview of the morphological techniques and approaches developed over the past 70 years to specifically label, identify and visualise peroxisomes in mammals, yeast and plants. We discuss the historical milestones that led to the first visualisation of peroxisomes in these organisms and trace the evolution of imaging strategies from early cytochemical and electron microscopy methods to modern fluorescence-based and high-resolution techniques. By highlighting the contribution of these approaches to advances in peroxisome biology, this review aims to place current peroxisome visualisation methods in a historical and methodological context.
- 20 May 2026
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 164 (1)
Open AccessVisualisation of peroxisomes: a journey through seven decades
Peroxisomes are ubiquitous, oxidative organelles in eukaryotes with conserved functions in cellular lipid metabolism and redox balance. They are now recognised as key metabolic organelles of medical importance, with contributions to antiviral signalling, pathogen defence, innate immunity, cancer and neurodegeneration. Our current knowledge of peroxisomes and the molecular understanding of their diverse functions and roles in disease have been achieved through a combination of biochemical and morphological studies. This review provides a comprehensive overview of the morphological techniques and approaches developed over the past 70 years to specifically label, identify and visualise peroxisomes in mammals, yeast and plants. We discuss the historical milestones that led to the first visualisation of peroxisomes in these organisms and trace the evolution of imaging strategies from early cytochemical and electron microscopy methods to modern fluorescence-based and high-resolution techniques. By highlighting the contribution of these approaches to advances in peroxisome biology, this review aims to place current peroxisome visualisation methods in a historical and methodological context.
- 25 February 2026
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 164 (1) , 10
Obituary—Prof. Dr. H. Dariush Fahimi
- 25 February 2026
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 164 (1) , 10
Obituary—Prof. Dr. H. Dariush Fahimi
- Top Cited Papers
- 10 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6756) , 157-162
ROS transfer at peroxisome-mitochondria contact regulates mitochondrial redox
Maintenance of mitochondrial redox homeostasis is of fundamental importance to cellular health. Mitochondria harbor a host of intrinsic antioxidant defenses, but the contribution of extrinsic, nonmitochondrial antioxidant mechanisms is less well understood. We found a direct role for peroxisomes in maintaining mitochondrial redox homeostasis through contact-mediated reactive oxygen species (ROS) transfer. We found that ACBD5 and PTPIP51 form a contact between peroxisomes and mitochondria. The percentage of these contacts increased during mitochondrial oxidative stress and helped to maintain mitochondrial health through the transfer of mitochondrial ROS to the peroxisome lumen. Our findings reveal a multiorganelle layer of mitochondrial antioxidant defense—suggesting a direct mechanism by which peroxisomes contribute to mitochondrial health—and broaden the scope of known membrane contact site functions.
- 10 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6756) , 157-162
Top Cited PapersROS transfer at peroxisome-mitochondria contact regulates mitochondrial redox
Maintenance of mitochondrial redox homeostasis is of fundamental importance to cellular health. Mitochondria harbor a host of intrinsic antioxidant defenses, but the contribution of extrinsic, nonmitochondrial antioxidant mechanisms is less well understood. We found a direct role for peroxisomes in maintaining mitochondrial redox homeostasis through contact-mediated reactive oxygen species (ROS) transfer. We found that ACBD5 and PTPIP51 form a contact between peroxisomes and mitochondria. The percentage of these contacts increased during mitochondrial oxidative stress and helped to maintain mitochondrial health through the transfer of mitochondrial ROS to the peroxisome lumen. Our findings reveal a multiorganelle layer of mitochondrial antioxidant defense—suggesting a direct mechanism by which peroxisomes contribute to mitochondrial health—and broaden the scope of known membrane contact site functions.
- Open Access
- 2 July 2025
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 18, 1602343
The neurological pathology of peroxisomal ACBD5 deficiency – lessons from patients and mouse models
The absence or dysfunction of the peroxisomal membrane protein Acyl-CoA Binding Domain-Containing Protein 5 (ACBD5) is the cause of the most recently discovered peroxisomal disorder “Retinal Dystrophy with Leukodystrophy” (RDLKD). ACBD5 is a tail-anchored protein, anchored by its C-terminus into the peroxisomal membrane; hence, the bulk of its amino acid sequence faces the cytosol. With respect to ACBD5’s molecular functions, RDLKD is unique since it is not only an accessory protein for the import of very-long-chain fatty acids (VLCFAs) into peroxisomes but also the first identified peroxisomal tethering protein facilitating membrane contacts with the endoplasmic reticulum (ER). Consequently, RDLKD is neither a peroxisomal biogenesis disorder nor single enzyme deficiency, since a deficiency in ACBD5 likely affects several aspects of peroxisomal function including VLCFA degradation, ether lipid synthesis, docosahexaenoic acid synthesis but also the transfer of membrane lipids from the ER to peroxisomes. Hence, RDLKD appears to be a multifactorial disorder leading to a mosaic pathology, combining symptoms caused by the disruption of several pathways. In this review, we will highlight recent findings obtained from case reports of RDLKD patients as well as insights from ACBD5-deficient mouse models to better understand its complex retinal and brain pathology. Moreover, we will discuss the possible contribution of the different dysregulated metabolites in the neurological pathogenesis of this latest peroxisomal disorder.
- 2 July 2025
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 18, 1602343
Open AccessThe neurological pathology of peroxisomal ACBD5 deficiency – lessons from patients and mouse models
The absence or dysfunction of the peroxisomal membrane protein Acyl-CoA Binding Domain-Containing Protein 5 (ACBD5) is the cause of the most recently discovered peroxisomal disorder “Retinal Dystrophy with Leukodystrophy” (RDLKD). ACBD5 is a tail-anchored protein, anchored by its C-terminus into the peroxisomal membrane; hence, the bulk of its amino acid sequence faces the cytosol. With respect to ACBD5’s molecular functions, RDLKD is unique since it is not only an accessory protein for the import of very-long-chain fatty acids (VLCFAs) into peroxisomes but also the first identified peroxisomal tethering protein facilitating membrane contacts with the endoplasmic reticulum (ER). Consequently, RDLKD is neither a peroxisomal biogenesis disorder nor single enzyme deficiency, since a deficiency in ACBD5 likely affects several aspects of peroxisomal function including VLCFA degradation, ether lipid synthesis, docosahexaenoic acid synthesis but also the transfer of membrane lipids from the ER to peroxisomes. Hence, RDLKD appears to be a multifactorial disorder leading to a mosaic pathology, combining symptoms caused by the disruption of several pathways. In this review, we will highlight recent findings obtained from case reports of RDLKD patients as well as insights from ACBD5-deficient mouse models to better understand its complex retinal and brain pathology. Moreover, we will discuss the possible contribution of the different dysregulated metabolites in the neurological pathogenesis of this latest peroxisomal disorder.
- 1 May 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (9)
Integrated proteome and lipidome analyses place OCIAD1 at the mitochondria–peroxisome intersection balancing lipid metabolism
Ovarian cancer immunoreactive antigen domain-containing 1 (OCIAD1) is a membrane protein largely localized to mitochondria; however, its function in health or disease is not well understood. To comprehensively characterize the molecular changes upon lack of OCIAD1, we used mass spectrometry to study the mitochondrial and cellular proteome and lipidome. We show that there is extensive lipidome rearrangement in OCIAD1 knockout (KO) cells, characterized by two main phenotypes of decreased levels of ether phospholipids and decreased levels of phospholipids with an odd number of carbons. The lipidomic changes suggest alterations in peroxisomal lipid metabolism. At the same time, proteins responsible for mitochondrial fatty acid β-oxidation are significantly increased. Together with a global loss in peroxisomal proteins, aberrant peroxisomal morphology, and a meta-analysis of proximity labeling data, this gives a function to the previously observed partial localization of OCIAD1 to peroxisomes. We suggest a role for OCIAD1 in balancing mitochondrial and peroxisomal lipid metabolism, and a direct impact on the key enzymes FAR1 and ABCD3.
- 1 May 2025
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (9)
Integrated proteome and lipidome analyses place OCIAD1 at the mitochondria–peroxisome intersection balancing lipid metabolism
Ovarian cancer immunoreactive antigen domain-containing 1 (OCIAD1) is a membrane protein largely localized to mitochondria; however, its function in health or disease is not well understood. To comprehensively characterize the molecular changes upon lack of OCIAD1, we used mass spectrometry to study the mitochondrial and cellular proteome and lipidome. We show that there is extensive lipidome rearrangement in OCIAD1 knockout (KO) cells, characterized by two main phenotypes of decreased levels of ether phospholipids and decreased levels of phospholipids with an odd number of carbons. The lipidomic changes suggest alterations in peroxisomal lipid metabolism. At the same time, proteins responsible for mitochondrial fatty acid β-oxidation are significantly increased. Together with a global loss in peroxisomal proteins, aberrant peroxisomal morphology, and a meta-analysis of proximity labeling data, this gives a function to the previously observed partial localization of OCIAD1 to peroxisomes. We suggest a role for OCIAD1 in balancing mitochondrial and peroxisomal lipid metabolism, and a direct impact on the key enzymes FAR1 and ABCD3.
- Open Access
Modelling Peroxisomal Disorders in Zebrafish
Peroxisomes are ubiquitous, dynamic, oxidative organelles with key functions in cellular lipid metabolism and redox homeostasis. They have been linked to healthy ageing, neurodegeneration, cancer, the combat of pathogens and viruses, and infection and immune responses. Their biogenesis relies on several peroxins (encoded by PEX genes), which mediate matrix protein import, membrane assembly, and peroxisome multiplication. Defects in peroxins or peroxisomal enzymes can result in severe disorders, including developmental and neurological abnormalities. The drive to understand the role of peroxisomes in human health and disease, as well as their functions in tissues and organs or during development, has led to the establishment of vertebrate models. The zebrafish (Danio rerio) has become an attractive vertebrate model organism to investigate peroxisomal functions. Here, we provide an overview of the visualisation of peroxisomes in zebrafish, as well as the peroxisomal metabolic functions and peroxisomal protein inventory in comparison to human peroxisomes. We then present zebrafish models which have been established to investigate peroxisomal disorders. These include model zebrafish for peroxisome biogenesis disorders/Zellweger Spectrum disorders, and single enzyme deficiencies, particularly adrenoleukodystrophy and fatty acid beta-oxidation abnormalities. Finally, we highlight zebrafish models for deficiencies of dually targeted peroxisomal/mitochondrial proteins. Advantages for the investigation of peroxisomes during development and approaches to the application of zebrafish models for drug screening are discussed.
Open AccessModelling Peroxisomal Disorders in Zebrafish
Peroxisomes are ubiquitous, dynamic, oxidative organelles with key functions in cellular lipid metabolism and redox homeostasis. They have been linked to healthy ageing, neurodegeneration, cancer, the combat of pathogens and viruses, and infection and immune responses. Their biogenesis relies on several peroxins (encoded by PEX genes), which mediate matrix protein import, membrane assembly, and peroxisome multiplication. Defects in peroxins or peroxisomal enzymes can result in severe disorders, including developmental and neurological abnormalities. The drive to understand the role of peroxisomes in human health and disease, as well as their functions in tissues and organs or during development, has led to the establishment of vertebrate models. The zebrafish (Danio rerio) has become an attractive vertebrate model organism to investigate peroxisomal functions. Here, we provide an overview of the visualisation of peroxisomes in zebrafish, as well as the peroxisomal metabolic functions and peroxisomal protein inventory in comparison to human peroxisomes. We then present zebrafish models which have been established to investigate peroxisomal disorders. These include model zebrafish for peroxisome biogenesis disorders/Zellweger Spectrum disorders, and single enzyme deficiencies, particularly adrenoleukodystrophy and fatty acid beta-oxidation abnormalities. Finally, we highlight zebrafish models for deficiencies of dually targeted peroxisomal/mitochondrial proteins. Advantages for the investigation of peroxisomes during development and approaches to the application of zebrafish models for drug screening are discussed.
- Open Access
- 18 January 2025
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 163 (1) , 1-10
Seventy years of peroxisome research: current advances and future perspectives
- 18 January 2025
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 163 (1) , 1-10
Open AccessSeventy years of peroxisome research: current advances and future perspectives
- Open Access
- 11 September 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1871 (8) , 119843
New insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms
- 11 September 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1871 (8) , 119843
Open AccessNew insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms
- Open Access
New insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms
Acyl-CoA binding domain-containing proteins (ACBDs) perform diverse but often uncharacterised functions linked to cellular lipid metabolism. Human ACBD4 and ACBD5 are closely related peroxisomal membrane proteins, involved in tethering of peroxisomes to the ER and capturing fatty acids for peroxisomal β-oxidation. ACBD5 deficiency causes neurological abnormalities including ataxia and white matter disease. Peroxisome-ER contacts depend on an ACBD4/5-FFAT motif, which interacts with ER-resident VAP proteins. As ACBD4/5-like proteins are present in most fungi and all animals, we combined phylogenetic analyses with experimental approaches to improve understanding of their evolution and functions. Notably, all vertebrates exhibit gene sequences for both ACBD4 and ACBD5, while invertebrates and fungi possess only a single ACBD4/5-like protein. Our analyses revealed alterations in domain structure and FFAT sequences, which help understanding functional diversification of ACBD4/5-like proteins. We show that the Drosophila melanogaster ACBD4/5-like protein possesses a functional FFAT motif to tether peroxisomes to the ER via Dm_Vap33. Depletion of Dm_Acbd4/5 caused peroxisome redistribution in wing neurons and reduced life expectancy. In contrast, the ACBD4/5-like protein of the filamentous fungus Ustilago maydis lacks a FFAT motif and does not interact with Um_Vap33. Loss of Um_Acbd4/5 resulted in an accumulation of peroxisomes and early endosomes at the hyphal tip. Moreover, lipid droplet numbers increased and mitochondrial membrane potential declined, implying altered lipid homeostasis. Our findings reveal differences between tethering and metabolic functions of ACBD4/5-like proteins across evolution, improving our understanding of ACBD4/5 function in health and disease. The need for a unifying nomenclature for ACBD proteins is discussed.
Open AccessNew insights into the functions of ACBD4/5-like proteins using a combined phylogenetic and experimental approach across model organisms
Acyl-CoA binding domain-containing proteins (ACBDs) perform diverse but often uncharacterised functions linked to cellular lipid metabolism. Human ACBD4 and ACBD5 are closely related peroxisomal membrane proteins, involved in tethering of peroxisomes to the ER and capturing fatty acids for peroxisomal β-oxidation. ACBD5 deficiency causes neurological abnormalities including ataxia and white matter disease. Peroxisome-ER contacts depend on an ACBD4/5-FFAT motif, which interacts with ER-resident VAP proteins. As ACBD4/5-like proteins are present in most fungi and all animals, we combined phylogenetic analyses with experimental approaches to improve understanding of their evolution and functions. Notably, all vertebrates exhibit gene sequences for both ACBD4 and ACBD5, while invertebrates and fungi possess only a single ACBD4/5-like protein. Our analyses revealed alterations in domain structure and FFAT sequences, which help understanding functional diversification of ACBD4/5-like proteins. We show that the Drosophila melanogaster ACBD4/5-like protein possesses a functional FFAT motif to tether peroxisomes to the ER via Dm_Vap33. Depletion of Dm_Acbd4/5 caused peroxisome redistribution in wing neurons and reduced life expectancy. In contrast, the ACBD4/5-like protein of the filamentous fungus Ustilago maydis lacks a FFAT motif and does not interact with Um_Vap33. Loss of Um_Acbd4/5 resulted in an accumulation of peroxisomes and early endosomes at the hyphal tip. Moreover, lipid droplet numbers increased and mitochondrial membrane potential declined, implying altered lipid homeostasis. Our findings reveal differences between tethering and metabolic functions of ACBD4/5-like proteins across evolution, improving our understanding of ACBD4/5 function in health and disease. The need for a unifying nomenclature for ACBD proteins is discussed.